Valeant Canada is a specialty pharmaceutical company that manufactures, markets and/or distributes pharmaceutical products and medical devices to primary care and specialist physicians in Canada. The company focuses its efforts primarily in the areas of dermatology, cardiovascular disease, neurology and eye health.

Valeant’s commercial and manufacturing operations are based in Laval, Quebec, and its strong commercial infrastructure makes it a logical partner for other companies seeking innovative ways to enter the Canadian market without the risk and expense of building their own operational organization from the ground up.

In addition to a strong prescription product portfolio, Valeant has established a strong presence with non-prescription retail brands such as Dr. Renaud™, COLD-FX® and Swiss Natural®.

In 2011, Valeant established an R&D center of excellence for consumer dermatology in Laval and recently launched its U.S.-developed skin care product line, CeraVe®, in Canada.

Following Valeant’s 2013 acquisition of eye health company Bausch + Lomb, Valeant has begun to establish itself as a major player in the eye health market within Canada as well.